Transgene SA (TRNG.PA)
25 May 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|57||2010||Chairman of the Board, Chief Executive Officer, Member of the Management Committee|
|53||2007||Deputy Chief Executive Officer, Qualified Pharmacist, Director of Quality Assurance and Compliance, Member of the Management Committee|
|2014||Executive Vice President, Vice President - Research & Development, Member of the Management Committee|
|2014||Vice President - Finance, Member of the Management Committee|
|48||2010||Vice President Industrial and Pharmaceutical Operations, Member of the Management Committee|
- BRIEF-Transgene Q1 Operating Revenue Stable At 1.8 Million Euros
- BRIEF-Transgene Says PCPV Most Promising Therapeutic Candidate Amongst Evaluated Poxviridae
- BRIEF-Transgene To Announce Major Clinical Results In 2018
- BRIEF-Transgene Says First Patient Dosed In China In Trial Of T101
- BRIEF-Transgene Announces Dosing Of First Patient In Phase 2 Trial Of TG4010 Evaluation